尿液代谢物及常见与罕见遗传变异与突发慢性肾脏病相关
在Framingham子代队列中,193例突发CKD(eGFR<60 ml/min/1.73m2)患者与193例年龄性别匹配对照比较,尿甘氨酸和组氨酸升高与CKD风险降低相关,OR分别为0.59和0.65;外显子芯片分析发现30个基因座36个SNP与31种代谢物相关,rs8101881与赖氨酸和NMMA水平升高相关,后两者与CKD风险降低相关。
要点
- 尿甘氨酸和组氨酸每升高1个标准差,突发CKD风险分别降低(OR 0.59和0.65)。
- ARIC队列验证了尿甘氨酸与CKD的关联。
- SLC7A9的rs8101881与尿赖氨酸和NMMA升高相关,二者与CKD风险降低相关。
核心结论
- 低尿甘氨酸和组氨酸与突发CKD相关。
- 尿液代谢组学的基因组关联分析将赖氨酸和NMMA与CKD联系起来,并为SLC7A9与肾脏疾病的关联提供了额外证据。
研究设计与样本
- Framingham子代队列研究,纳入193例在第6次(1995-1998年)至第8次(2005-2008年)检查期间发生CKD(eGFR<60 ml/min/1.73m2)的个体,平均随访9.7年,并与193例无CKD的年龄性别匹配对照比较。
- 使用质谱法测量154种尿液代谢物,采用逻辑回归分析代谢物与CKD的关联。
- 使用Illumina外显子芯片检测每个代谢物的遗传关联。
- 在ARIC队列中对尿甘氨酸与CKD的关联进行随访验证。
主要发现
- 尿甘氨酸和组氨酸浓度每升高1个标准差,突发CKD的OR分别为0.59(95%CI 0.43-0.80)和0.65(95%CI 0.50-0.85)。
- ARIC队列验证了尿甘氨酸与CKD的关联。
- 外显子芯片分析中,30个基因座的36个单核苷酸多态性与31种代谢物显著相关。
- rs8101881(SLC7A9,编码氨基酸转运蛋白)与尿赖氨酸和NMMA水平升高显著相关。
- 在单变量模型中,尿赖氨酸和NMMA升高与CKD风险降低相关,OR分别为0.73(95%CI 0.50-0.90)和0.66(95%CI 0.53-0.83)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We assessed the association between urinary metabolites, genetic variants, and incident chronic kidney disease (CKD) in the Framingham Offspring cohort. Among the participants, 193 individuals developed CKD (estimated glomerular filtration rate under 60 ml/min/1.73m2) between cohort examinations 6 (1995-1998) and 8 (2005-2008, mean follow-up 9.7 years). They were age- and sex-matched to 193 control individuals free of CKD. A total of 154 urinary metabolites were measured using mass spectrometry, and the association between metabolites and CKD was examined using logistic regression. Next, we tested the genetic associations of each metabolite with an Illumina exome chip. Urinary glycine and histidine were associated with a lower risk of incident CKD with an odds ratio of 0.59 (95% confidence interval [CI] 0.43-0.80) and 0.65 (0.50-0.85) respectively, per one standard deviation increase in metabolite concentration. Follow-up in the Atherosclerosis Risk in Communities cohort confirmed the association of urinary glycine with CKD. In exome chip analyses, 36 single nucleotide polymorphisms at 30 loci were significantly associated with 31 metabolites. We surveyed exome chip findings for associations with known renal function loci such as rs8101881 in SLC7A9 coding for an amino acid transporter, which has been associated with a lower risk of CKD. We found this polymorphism was significantly associated with higher levels of lysine and NG-monomethyl-L-arginine (NMMA). Increased urinary lysine and NMMA were associated with a lower risk of CKD (0.73 [0.50-0.90] and 0.66 [0.53-0.83], respectively) in the univariate model. Thus, low urinary glycine and histidine are associated with incident CKD. Furthermore, genomic association of urinary metabolomics identified lysine and NMMA as being linked with CKD and provided additional evidence for the association of SLC7A9 with kidney disease.
引用
- McMahon GM, Hwang SJ, Clish CB, et al. Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease. Kidney Int. 2017. PMID: 28302371. doi:10.1016/j.kint.2017.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。